Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Bifidobacterium animalis lactis + Lacticaseibacillus rhamnosus & Diarrhoea / Diarrhea (Chemotherapy (CT)-induced)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

The randomized clinical phase III prevention trial NCT02819960 - Bifidobacterium animalis lactis BB-12 + Lacticaseibacillus rhamnosus GG (LGG) & Diarrhoea / Diarrhea (Chemotherapy (CT)-induced) revealed that the administration of probiotics did not lead to a significant reduction in grade 3/4 diarrhea
Mego et al. 2023 Front Oncol 13: 1168654

…

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients
Mego et al. 2023 Front Oncol 13: 1168654

7/1/2026